WeForNews | Latest News, Breaking News, News Updates To cover Modi's dilemma BJP claims international conspiracy in questioning Rafale deal, says Kapil Sibal | WeForNews | Latest News, Blogs
Connect with us

India

To cover Modi’s dilemma BJP claims international conspiracy in questioning Rafale deal, says Kapil Sibal

Published

on

Kapil Sibal

New Delhi, Sep 25 : Senior Congress leader Kapil Sibal said Prime Minister Narendra Modi is in a dilemma what to disclose about Rafale deal and to cover that scam, defence minister Nirmala Sitharaman is now claiming that Rafale aircraft deal is being questioned by the Opposition because of an international conspiracy.

Sibal went ahead saying, ” Modi should change  his government’s slogan from ‘na khayenge, na khane denge’ to “na main bataoga a batanedooga.”

“Where is the international conspiracy,We wanted Rafale deal to go through, which would generate thousands of jobs. I want to ask Nirmala Sitharaman where did she come across international conspiracy,” Kapil Sibal said.

Modi never constituted Lokpal because of Rafale Scam

Targeting Modi, Kapil Sibal said, “Now, we know why Lokpal was never constituted because then people would know the truth about Rafalegate.”

“There are disputed facts. We are hoping PM Modi will clarify who and how one benefited by sidelining HAL. 22000 jobs would’ve been created if HAL was awarded the deal. Transfer of technology was included in the UPA deal,” Sibal said.

“Modi is in a dilemma whether he should agree that ex-French president Francois Hollande is telling the truth about the Rafale deal or Hollande is telling lies (Modi has no evidence or argument to support his lies), Modi is in a fix what to say, purchase toh karliya par lena ke, dene pargayee,” Sibal said.

“This is the for the first time in the history of India that Prime Minister Narendra Modi acted in an individual manner to sign a deal without discussing with the government.He changed the nature of the deal thinking he is entitled to and changed the global tender and made it a government to government agreement,”Kapil said.

Sibal further questioned on what basis an individual can change the deal of a country, ” he is not entitled to do anything on what he likes.”

“Nor Manohar Parrikar, Arun Jaitley or Nirmala Sithjaraman – none of them were aware of the new deal announced by PM. Only two people knew- then French President Hollande and PM Modi, so in a court the best evidence we have of Hollande , “Sibal said.

Narendra Modi and ANil AMbani kin the Rafale deal and its connection with Anil Ambani,

Launching  a scathing attack on Prime Minister Narendra Modi in the Rafale deal and its connection with Anil Ambani, the Congress leader said that the “businessman friend’s” Reliance Defence was incorporated when the aircraft deal was announced. Speaking at a press conference, Congress leader Kapil Sibal said that the deal was made to favour Ambani.

“On March 28, 2015, Reliance Defence Limited was incorporated. On March 25, 2015, Eric Trappier stated that contract with HAL was finalised. On March 11, 2015, HAL and Dassault stated parts of Rafale manufactured by HAL and Dassault will be guaranteed by respective companies,” Sibal said.

The Congress leader further alleged that only former French president Francois Hollande and PM Narendra Modi were aware of the Rafale deal. “On April 8, 2015, Foreign Secretary of India stated Rafale deal wasn’t on the table during PM’s visit to France on April 10, 2015. But PM announced about the 36 Rafale aircrafts deal, while none of them were aware,” he said.

” Two  weeks after the new deal was announced, on 24th April, 2015, Reliance Aerostructure Ltd was incorporated. Somehow both PM Modi and Reliance knew about the new deal all along. Only HAL didn’t know. Manohar Parrikar, Arun Jaitley or Nirmala Sitharaman none of them were aware of the new deal announced by PM. Only two people knew — then French President Hollande and PM Modi,” the allegation continued.

“Why did they take decision on Rafale deal on April 10? We are only asking for the price, not the technology,” he said.

While concluding his press conference, Sibal pointed out that Modi must reply to the Rafale questions when he addressees rallies or give lengthy speeches.

Cities

Delhi reports 51 cases of minor adverse events post vaccination

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Published

on

By

Covid 19 Vaccine

Hours after the Health Ministry announced on January 16 that India has reported no case of post-vaccination hospitalisation yet, 51 persons complained of minor adverse events in Delhi. Another person developed severe adverse event following immunization and had to be referred to the AEFI centre.

Out of a total of 4,319 healthcare and frontline workers who were vaccinated on Jnauary 16 in the National Capital, two healthcare workers at NDMC’s Charak Palika Hospital reported mild adverse event post-vaccination including mild tightness in the chest. They were kept under observation by AEFI team and discharged 30 minutes later after they felt at ease. The two other cases were reported from Northern Railway Central Hospital, of which one was referred to the AEFI centre, the Delhi government has informed.

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Beneficiaries from 11 states and union territories across India received Covishield or Covaxin shots on the first day of the vaccination drive, namely, Assam, Bihar, Delhi, Haryana, Karnataka, Maharashtra, Odisha, Rajasthan, Tamil Nadu, Telangana, and Uttar Pradesh.

Follow our coverage of the coronavirus crisis here

Continue Reading

Health

Bharat Biotech to pay compensation if Covaxin causes side-effects

The vaccine maker said in phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19

Published

on

By

COVAXIN Corona Covid vaccine

Hyderabad, January 16: Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company would pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.

In the consent form to be signed by the vaccine recipients, Bharat Biotech said: “In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals.”

“The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine,” the consent form said.

In phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19. However, the clinical efficacy of the vaccine was yet to be established and it was still being studied in phase 3 clinical trials, the vaccine maker said.

“Hence it is important to appreciate that receiving the vaccine does not mean that other precautions related to COVID-19 need not be followed,” the consent form said.

According to an industry expert, the company is liable to pay compensation to people in case of serious side effects as the vaccine is being administered while in the clinical trial mode.

The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial mode.

Meanwhile, Suchitra Ella, joint managing director, Bharat Biotech International Limited, on her Twitter account said: “Covaxin & Bharat Biotech is truly humbled & honoured to be of service to the nation & the fraternity of all first responders of covid who have served public health.” — PTI

Continue Reading

Cities

AIIMS security guard reports allergy post COVID vaccination, in hospital care

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

Published

on

By

Vaccine

New Delhi, January 16

A 22-year-old security guard at AIIMS, New Delhi reported allergic reaction and is learnt to be in intensive care, moments after the government said there was no post-vaccine hospitalisation.

The 22-year-old guard developed headache, rash, respiratory distress, tachycardia after vaccination. He is in ICU and his condition is stable, hospital sources said.

Delhi has reported 52 adverse events following events of which one is serious and could involve the guard hospitalised today.

All beneficiaries vaccinated at AIIMS got indigenous COVAXIN.

Continue Reading
Advertisement

Most Popular